Skip to main content


GIN is a member of the MyoNeurALP alliance created in 2016 to gather the community of researchers and clinicians of the Auvergne-Rhone-Alpes developing research on neuromuscular diseases.

MyoNeurALP is a reference center for rare neuromuscular diseases with expertise at all levels of the neuromuscular system (neurons, neuromuscular junction, muscle, immune cells, endothelial cells…) that associates 17 multidisciplinary teams from four research units (INMG-NeuroMyoGene Institute, Lyon, GReD Genetique Reproduction and Developpement, Clermont Ferrand, GIN Grenoble Neurosciences, LIBM (former LPE) Laboratoire Interuniversitaire de Biologie de la Motricite, Saint Etienne).

MyoNeurALP aim is to gain further understanding of pathophysiological mechanisms, identify new biomarkers and propose innovative therapeutic strategies for neuromuscular disorders. The approaches are developed at multidimensional scales ranging from molecular biology, cell biology, electrophysiology to integrated human physiology.



Submitted on February 6, 2024

Updated on February 6, 2024